ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Literature Review Supports Need for More Research In Cancer Control

July 19, 1985

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

New Treatment Approaches for Leukemias Emerging From Early Clinical Trials

December 31, 2004

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987